Retatrutide 3XL 5 mg 30 kapsúl

Popis

The product is supplied exclusively for scientific research and laboratory applications. It is not intended for human consumption and is not classified as a food supplement or medicinal product.

Retatrutide 3XL – Next Generation Metabolic Research Peptide

Exploring the future of advanced peptide-based metabolic research

Retatrutide is an investigational research molecule referenced in scientific literature for its unique triple receptor agonist mechanism involving GLP-1R, GIPR, and GCGR.

This next-generation synthetic peptide represents a new approach in metabolic science by combining three receptor pathways within a single molecular structure. The “3G” designation refers to this triple receptor activity targeting GLP-1, GIP, and glucagon receptor pathways.

How this works

Retatrutide is being studied for its interaction with key metabolic receptors involved in signaling pathways related to energy balance, glucose metabolism, and body weight regulation.

Unlike single-receptor approaches, this molecule represents a multi-target research strategy designed to explore the combined effects of three important metabolic pathways within one peptide structure.

Advanced peptide delivery research

Retatrutide 3XL utilizes advanced formulation concepts, including liposomal delivery technology combined with SNAC-based approaches.

This technology is being investigated for its potential role in peptide stability, protection, and oral delivery mechanisms. The capsule-based format provides a convenient platform for research applications focused on peptide formulation and delivery science.

Why is it called a 3G peptide?

The term “3G” refers to the three metabolic receptor pathways associated with this research molecule:

GLP-1R
Studied for its role in metabolic signaling pathways related to appetite regulation and glucose metabolism.

GIPR
Investigated for its interaction with glucose-dependent metabolic processes.

GCGR (Glucagon receptor)
Studied for its involvement in energy metabolism pathways.

The combination of these three receptor pathways has made Retatrutide one of the most closely watched investigational peptide molecules in modern metabolic research.

Retatrutide vs. traditional GLP-1 research approaches

Many established peptide research approaches focus on individual receptor pathways. Retatrutide represents a broader multi-receptor strategy by combining GLP-1, GIP, and glucagon receptor activity within a single molecule.

This multi-pathway approach continues to attract interest among researchers investigating the complex relationship between metabolism, energy balance, and receptor signaling.

Research background

Retatrutide has been the subject of extensive scientific investigation since 2022 and continues to be evaluated within clinical research programs exploring metabolic pathways and physiological mechanisms.

Research interest has focused on areas including:

• metabolic receptor signaling
• glucose metabolism pathways
• energy balance mechanisms
• peptide-based therapeutic research strategies

Research areas of Retatrutide

Research into Retatrutide has focused on several areas of metabolic science, including:

Obesity and body weight regulation

Clinical research programs have investigated Retatrutide in relation to body weight changes, metabolic pathways, and mechanisms involved in weight regulation.

Glucose metabolism

Studies have explored its interaction with metabolic signaling pathways associated with glucose metabolism and insulin-related processes.

Energy metabolism

Research has examined multi-receptor peptide approaches and their role in understanding energy balance and metabolic mechanisms.

Product format

Retatrutide 3XL is supplied in capsule format for research applications.

Composition:

• Retatrutide research compound – 5 mg
• Liposomal blend – 500 mg
• SNAC (Sodium N-(8-(2-hydroxybenzoyl)amino)caprylate) – 120 mg
• Inulin – 100 mg
• L-Leucine – 100 mg
• Ascorbic Acid – 100 mg

Packaging

Available in 30 capsules, suitable for extended research and evaluation periods.

Research disclaimer

Retatrutide 3XL is a research product intended exclusively for scientific research purposes. It is not a dietary supplement, medicine, or medical product. The information provided is based on available scientific literature and manufacturer documentation and does not represent medical claims or guarantees of results.